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Integrin α5β1 expression on 
dopaminergic neurons is involved in 
dopaminergic neurite outgrowth on 
striatal neurons
Yasuhiko Izumi1, Seiko Wakita1, Chisato Kanbara1, Toshie Nakai1, Akinori Akaike1,2 & 
Toshiaki Kume1
During development, dopaminergic neurons born in the substantia nigra extend their axons toward 
the striatum. However, the mechanisms by which the dopaminergic axons extend the striatum to 
innervate their targets remain unclear. We previously showed that paired-cultivation of mesencephalic 
cells containing dopaminergic neurons with striatal cells leads to the extension of dopaminergic 
neurites from the mesencephalic cell region to the striatal cell region. The present study shows that 
dopaminergic neurites extended along striatal neurons in the paired-cultures of mesencephalic cells 
with striatal cells. The extension of dopaminergic neurites was suppressed by the pharmacological 
inhibition of integrin α5β1. Using lentiviral vectors, short hairpin RNA (shRNA)-mediated knockdown 
of integrin α5 in dopaminergic neurons suppressed the neurite outgrowth to the striatal cell region. 
In contrast, the knockdown of integrin α5 in non-dopaminergic mesencephalic and striatal cells had 
no effect. Furthermore, overexpression of integrin α5 in dopaminergic neurons differentiated from 
embryonic stem cells enhanced their neurite outgrowth on striatal cells. These results indicate that 
integrin α5β1 expression on dopaminergic neurons plays an important role in the dopaminergic neurite 
outgrowth on striatal neurons.
Dopaminergic neurons in the substantia nigra pars compacta project to the dorsolateral striatum, thus forming 
the nigrostriatal projection. In humans, a selective loss of this projection is a pathological hallmark of Parkinson 
disease (PD). Although the exact causes of neuronal loss remain unclear, the regeneration of this pathway shows 
great promise as a therapy for PD. Transplantation of fetal nigral dopamine neurons for PD patients gives rise to 
substantial symptomatic relief for a decade1, although it have been reported that dyskinesia occurs after trans-
plantation2. Olanow et al.3 suggest that it is likely that off-medication dyskinesia represent a variant of dipha-
sic dyskinesia due to incomplete or aberrant reinnervation of the striatum. To successfully reestablish the lost 
nigrostriatal pathway, considerable knowledge regarding the axon guidance signals present in the extracellular 
milieu is required.
In rat and mouse embryos, dopaminergic axons, which begin their projection in a dorsal direction from the 
ventrocaudal region of the midbrain, are rostrally guided by Wnt5a and Semaphorin 3F as chemorepellants and 
Wnt7b as a chemoattractant4–7. The dopaminergic axons rostrally elongate along the medial forebrain bundle 
as they move ventrally to the thalamus. Next, the axons are directed into the striatum via the repulsive effect of 
ephrin-A58. Although a correlation between dopaminergic innervation and the striatal distribution of glycos-
aminoglycans during the early postnatal period has been suggested9, it remains unclear how the dopaminergic 
axons extend to the striatum in order to innervate their targets.
To address this issue, we previously reconstructed the dopaminergic innervation of striatal cells using dis-
sociated primary cultures10. When mesencephalic cells containing dopaminergic neurons were adjacently 
paired-cultured with striatal cells, dopaminergic neurites extended from the mesencephalic cell region to the stri-
atal cell region. In addition, this paired-cultivation enables the quantitative evaluation of dopaminergic neurite 
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Figure 1. The effects of striatal cells on dopaminergic neurite outgrowth in paired-cultures of 
mesencephalic and striatal cells. (a) Scheme of paired-cultures of mesencephalic and striatal cells. A coverslip in 
a 35 mm culture dish was divided into two compartments with an isolation wall. Mesencephalic cells were plated 
inside the isolation wall and striatal cells were plated outside. The isolation wall was removed 24 h after plating. 
A microphotograph shows the vicinity of the borderline. The upper region is comprised of mesencephalic 
cells (Mes), and the lower region is comprised of striatal cells (St). Scale bar = 200 μ m. (b and c) Representative 
photographs of the dopaminergic innervation of striatal cells. Mesencephalic cells were paired-cultured with 
striatal cells for 10 days, and the paired-cultures were processed for TH, MAP2, pNF, and GFAP immunostaining 
and nuclear staining. Fluorescence images show the striatal cell region near the borderline. The lower images 
were high-power fields outlined by a square in the upper images. Scale bar = 200 μ m. (d) Striatal astrocytes had 
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outgrowth to the striatal cell region. In the present study, we pharmacologically and genetically examined the pre-
cise mechanisms behind the dopaminergic neurite outgrowth on striatal neurons in the paired-cultures. Here, we 
show that integrin α 5β 1 expression on dopaminergic neurons is involved in the dopaminergic neurite outgrowth 
on striatal neurons. In addition, we investigated the neurite outgrowth of integrin α 5-overexpressing dopaminer-
gic neurons derived from embryonic stem (ES) cells on striatal cultures.
Results
Dopaminergic neurite outgrowth on striatal neurons in paired-cultures of mesencephalic and 
striatal cells. Our previous study10 demonstrated that dopaminergic neurites extended from the mesen-
cephalic cell region to the striatal cell region after 10 days of paired-cultivation of mesencephalic and striatal 
cells (Fig. 1a). We used fluorescence staining to clarify the pattern of dopaminergic neurite outgrowth to the 
striatal cell region. Nuclear staining with Hoechst 33258 in the striatal cell region revealed that striatal cells 
formed clusters after 10 days in culture. The clusters of striatal cells were surrounded by microtubule associated 
protein 2 (MAP2)-positive dendrites of striatal neurons, suggesting that striatal neurons tended to form clus-
ters (Fig. 1b). Phosphorylated neurofilaments (pNF)-positive axons of striatal neurons connected the clusters 
(Fig. 1c). Importantly, tyrosine hydroxylase (TH)-positive dopaminergic neurites extended along the clusters of 
striatal neurons (Fig. 1b and c). Glial fibrillary acidic protein (GFAP)-positive astrocytes were mainly localized 
to the striatal cell region outside of the clusters (Fig. 1c). In our previous report10, synaptophysin was expressed 
at the growth cones of dopaminergic neurites which extended along the striatal neuronal clusters. To examine 
the involvement of striatal astrocytes in dopaminergic neurite outgrowth, mesencephalic cells were adjacently 
paired-cultured with striatal astrocytes for 10 days. The paired-cultivation with striatal astrocytes had no effect 
on dopaminergic neurite outgrowth (Fig. 1d). To examine the involvement of humoral factors from striatal cells 
in dopaminergic neurite outgrowth, mesencephalic cells were cultured in striatal cell-conditioned medium (CM) 
for 10 days. The striatal CM had no effect on dopaminergic neurite outgrowth (Fig. 1e). We previously reported 
that glial derived neurotrophic factor (GDNF) extended dopaminergic neurites beyond the mesencephalic cell 
region in mesencephalic cell cultures10. However, GDNF did not enhance dopaminergic neurite outgrowth to the 
striatal cell region in the paired-cultures of mesencephalic and striatal cells (Fig. 1f), suggesting that the signaling 
of GDNF was saturated.
Inhibition of integrin α5β1 suppressed dopaminergic neurite outgrowth to the striatal cell 
region. Cell adhesion molecules, such as neural cell adhesion molecule (NCAM) and integrin, play impor-
tant roles in the signaling of GDNF for dopaminergic neurite outgrowth11–13. The function-blocking antibody 
anti-NCAM (AB5032), which inhibited GDNF-induced dopaminergic neurite outgrowth (data not shown), 
had no effect on the dopaminergic neurite outgrowth to the striatal cell region in the paired-cultures of mes-
encephalic and striatal cells (Fig. 2a). In contrast, the synthetic Arg-Gly-Asp-Ser (RGDS) peptide, an inhibi-
tor of RGD-binding integrins, significantly suppressed neurite outgrowth, whereas treatment with a glutamic 
acid-substituted control peptide (RGES) showed no effect (Fig. 2b and c). To narrow down the candidates of inte-
grin heterodimers, the effects of more selective blocking peptides were examined. ATN-161 (Ac-PHSCN-NH2), 
which is derived from the synergy region of fibronectin, binds to both α 5β 1 and α Vβ 3 in vitro14. Cyclo(RGDfV), 
a cyclic pentapeptide containing the RGD sequence, is a selective α Vβ 3 antagonist15. A5-1 (VILVLF) is an antag-
onistic peptide against integrin α 5β 116. ATN-161 and A5-1 significantly suppressed dopaminergic neurite out-
growth to the striatal cell region, whereas treatment with cyclo(RGDfV) had no effect (Fig. 2d–f). To confirm 
the involvement of integrin α 5β 1, the effects of function-blocking antibodies were examined. Anti-integrin α 5 
(HMa5-1) and anti-integrin β 1 (Ha2/5) antibodies have function-blocking properties17,18. These antibodies sig-
nificantly suppressed dopaminergic neurite outgrowth to the striatal cell region, whereas treatment with control 
IgG had no effect (Fig. 2g–i).
Expression of integrin α5β1 in dopaminergic neurons. We examined the expression of integrin 
mRNA (integrin α 1, 2, 4, 5, 6, 7, 8, V, and β 1, 2, 3, 4, 5) in mesencephalic and striatal cultures. Whole-brain sam-
ples from adult rats were used as a positive control. Although there were differences in expression levels, all of the 
integrin mRNAs tested in this study were expressed, except for integrin β 4 in mesencephalic cultures and integrin 
α 2 in striatal cultures (Fig. 3a). Integrin α 5 and β 1 were expressed in dopaminergic soma (Fig. 3b). Furthermore, 
integrin α 5 and β 1 were intensely expressed in dopaminergic growth cones and varicosities (Fig. 3c). The per-
centage of dopaminergic neurons expressing integrin α 5 and β 1 was 96.7 ± 1.9% and 93.3 ± 2.1%, respectively. 
To examine the involvement of integrin α 5β 1 in dopaminergic neurite outgrowth, the outside of the mesence-
phalic cell region was coated with extracellular matrix. Fibronectin is a glycoprotein that binds to integrin α 5β 1. 
The fibronectin coating outside of the mesencephalic cell region enhanced dopaminergic neurite outgrowth in 
mesencephalic cell cultures. Collagen and laminin are extracellular matrices that bind to integrin family members 
other than integrin α 5β 1. The collagen type I coating enhanced dopaminergic neurite outgrowth, whereas the 
no effect on dopaminergic neurite outgrowth. Control (Mes) group: mesencephalic cells were cultured alone 
for 10 days. Mes + Striatal astrocytes group: mesencephalic cells were paired-cultured with astrocytes derived 
from the striatum. Mes/St group: mesencephalic cells were paired-cultured with striatal cells. (e) Striatal CM did 
not affect dopaminergic neurite outgrowth. Mes + Striatal CM group: mesencephalic cells were cultured in CM 
prepared from striatal cultures. (f) GDNF did not enhance dopaminergic neurite outgrowth in paired-cultures 
of mesencephalic and striatal cells. Mesencephalic cells only or paired-cultures of mesencephalic and striatal 
cells were incubated in the presence or absence of GDNF (10 ng/mL) for 10 days. *p < 0.05 and ***p < 0.001 vs. 
control (Mes) group. n.s.: not significant.
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laminin coating did not (Fig. 3d). A5-1 suppressed dopaminergic neurite outgrowth on fibronectin coating, but 
did not on collagen coating (Fig. 3e).
Knockdown of integrin α5 in mesencephalic cells suppressed dopaminergic neurite outgrowth 
to the striatal cell region. Integrin α 5β 1 was expressed in both mesencephalic and striatal cultures. To clar-
ify the involvement of integrin α 5β 1 expression on dopaminergic neurons in neurite outgrowth, we completed 
Figure 2. Involvement of cell adhesion molecules in dopaminergic neurite outgrowth to the striatal cell 
region. Mesencephalic cells were paired-cultured with striatal cells for 10 days in the presence or absence of 
function-blocking peptides and antibodies. **p < 0.01 and ***p < 0.001 vs. control (Mes/St) group.
www.nature.com/scientificreports/
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a lentiviral vector–mediated gene knockdown in mesencephalic cells. The silencing lentiviral vector constructs 
expressed both shRNA and Venus, which was as a marker gene (Fig. 4a). To produce mesencephalic cell-specific 
knockdown, the lentiviral vectors were applied to the inside of the isolation wall containing mesencephalic cells. 
The isolation wall was removed the next day after the lentiviral vectors were washed out. After paired-cultivation 
with striatal cells for 5 days, Venus was preferentially expressed in mesencephalic cells (Fig. 4b). Integrin α 5 
shRNA selectively decreased the expression of endogenous integrin α 5 in mesencephalic cells and had no detect-
able effect on the expression in striatal cells (Fig. 4c). After paired-cultivation with striatal cells for 10 days, immu-
nocytochemistry was performed using anti-green fluorescent protein (GFP) (for Venus) and anti-TH antibodies. 
Both lentiviral vectors, which expressed either control shRNA or integrin α 5 shRNA, infected approximately 
70% of the dopaminergic neurons (Fig. 4d and e). There was no difference in dopaminergic cell viability between 
vectors (Fig. 4f). Figure 4g shows that distribution of dopaminergic growth cones from the borderline of the 
Figure 3. Participation of integrin α5β1 in dopaminergic neurite outgrowth. (a) Expression of integrin 
mRNA in mesencephalic and striatal cultures. mRNA levels were analyzed using RT-PCR. (b and c) Expression 
of integrin α 5 and β 1 on dopaminergic neurons. Representative photographs of dopaminergic soma (b) and 
neurites (c). Mesencephalic cells were cultured alone for 10 days and then processed for immunostaining of TH, 
integrin α 5 and integrin β 1. Arrowheads indicate dopaminergic soma. Scale bars = 50 μ m (b) and 25 μ m (c).  
(d) Influence of the extracellular matrix on dopaminergic neurite outgrowth. The outside of the isolation wall 
was coated by fibronectin, collagen type I, or laminin (5 and 10 μ g/cm2). Mesencephalic cells were cultured 
alone for 10 days. (e) The effect of integrin α 5β 1 blocking peptide on dopaminergic neurite outgrowth on the 
extracellular matrix. The outside of the isolation wall was coated by fibronectin or collagen type I (10 μ g/cm2). 
Mesencephalic cells alone were cultured in the presence or absence of A5-1 (30 μ M) for 10 days. ***p < 0.001 vs. 
control (Mes) group. ###p < 0.001. n.s.: not significant.
www.nature.com/scientificreports/
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Figure 4. The effect of integrin α5 knockdown in mesencephalic cells on dopaminergic neurite outgrowth 
to the striatal cell region. (a) Structure of the lentiviral vector expressing shRNA and Venus under the control 
of the human H1 and human EF-1α promoters, respectively. (b) Preferential infection of mesencephalic cells 
with lentiviral vectors. Lentiviral vectors were applied inside the isolation wall during 5 to 24 hours after cell 
plating. Mesencephalic cells were paired-cultured with striatal cells for 5 days. Representative photographs show 
the vicinity of the borderline between the cell regions. Left: phase-contrast image. Right: Venus fluorescence. 
Scale bar = 200 μ m. (c) Selective knockdown of integrin α 5 in mesencephalic cells. Protein samples were 
separately collected from the mesencephalic and striatal cells of paired-cultures 6 days after infection with 
lentiviral vectors. β -Actin was used as a loading control. (d–f) The effects of lentiviral vectors on infection 
efficiency and cell density in dopaminergic neurons. After infection with lentiviral vectors, mesencephalic cells 
were paired-cultured with striatal cells for 10 days and then processed for immunostaining of Venus and TH. 
Arrowheads (d) indicate Venus-positive dopaminergic neurons. Scale bar = 50 μ m. n = 20. (g) Distribution of 
Venus-positive and Venus-negative dopaminergic growth cones from the borderline of the mesencephalic cell 
region. (h and i) The effect of integrin α 5 shRNA infection in mesencephalic cells on dopaminergic neurite 
outgrowth to the striatal cell region. Venus-positive (h) and Venus-negative (i) dopaminergic neurite lengths 
were summed. ***p < 0.001 vs. control shRNA. n.s.: not significant.
www.nature.com/scientificreports/
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mesencephalic cell region. In cultures transfected with integrin α 5 shRNA, the number of Venus-positive dopa-
minergic growth cones was decreased away from the borderline. Thus, transfection of mesencephalic cells with 
integrin α 5 shRNA significantly suppressed Venus-positive dopaminergic neurite outgrowth to the striatal cell 
region (Fig. 4h). There was no difference in the distribution of Venus-negative dopaminergic growth cones or the 
Venus-negative dopaminergic neurite outgrowth between control and integrin α 5 shRNA (Fig. 4g and i).
Knockdown of integrin α5 in striatal cells did not affect dopaminergic neurite outgrowth to the 
striatal cell region. To eliminate the possibility that integrin α 5β 1 expression in striatal cells is involved in 
dopaminergic neurite outgrowth, we selectively knock downed integrin α 5 in striatal cells. The lentiviral vectors 
Figure 5. The effect of integrin α5 knockdown in striatal cells on dopaminergic neurite outgrowth to the 
striatal cell region. (a) Preferential infection of striatal cells with lentiviral vectors. Lentiviral vectors were 
applied outside the isolation wall during 5 to 24 hours after cell plating. Mesencephalic cells were paired-
cultured with striatal cells for 5 days. Representative photographs show the vicinity of the borderline between 
the cell regions. Left: phase-contrast image. Right: Venus fluorescence. Scale bar = 200 μ m. (b) Selective 
knockdown of integrin α 5 in striatal cells. Protein samples were separately collected from the mesencephalic 
and striatal cells of paired-cultures 6 days after infection with lentiviral vectors. (c) Distribution of dopaminergic 
growth cones from the borderline of the mesencephalic cell region. (d) The effect integrin α 5 shRNA infection 
in striatal cells with on dopaminergic neurite outgrowth to the striatal cell region. After infection with lentiviral 
vectors, mesencephalic cells were paired-cultured with striatal cells for 10 days and then processed for TH 
immunostaining. TH-positive dopaminergic neurite lengths were summed. n.s.: not significant.
www.nature.com/scientificreports/
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were applied to the outside of the isolation wall containing striatal cells. After paired-cultivation with striatal cells 
for 5 days, Venus was preferentially expressed in striatal cells (Fig. 5a). Integrin α 5 shRNA selectively decreased 
the expression of endogenous integrin α 5 in striatal cells and had no detectable effect in mesencephalic cells 
(Fig. 5b). After paired-cultivation with striatal cells for 10 days, immunocytochemistry was performed using 
anti-TH antibodies. There was no difference in the distribution of dopaminergic growth cones or the dopaminer-
gic neurite outgrowth between control and integrin α 5 shRNA (Fig. 5c and d).
Overexpression of integrin α5 in ES cell-derived dopaminergic neurons enhanced dopaminer-
gic neurite outgrowth on striatal cultures. To confirm that integrin α 5β 1 expression on dopaminergic 
neurons participates in the neurite outgrowth on striatal neurons, we produced integrin α 5-overexpressing dopa-
minergic neurons from mouse ES cells. Full-length mouse integrin α 5 mRNA was isolated from the whole brain 
(Fig. 6a). cDNA was incorporated into a bicistronic IRES-Venus expression lentiviral vector (LV-integrin α 5). 
The control vector (LV-control) consisted of the lentiviral backbone vector with the gene encoding Venus 
(Fig. 6b). Mouse ES cells were transfected with these lentiviral vectors and cloned. We confirmed that undif-
ferentiated ES cells transfected with the vectors expressed Venus (Fig. 6c), LV-integrin α 5-transfected cells 
expressed integrin α 5, and undifferentiated ES cells did not express endogenous integrin α 5 (Fig. 6d). The cloned 
ES cells were differentiated with the stromal cell-derived inducing activity method (SDIA method), by which 
mesencephalic dopaminergic neurons are induced19. We confirmed that the mesencephalic dopaminergic neu-
ron markers Nurr1 and Ptx3 were induced in differentiated ES cells (Fig. 7a). After differentiation, LV-integrin 
α 5-transfected cells expressed more integrin α 5 than LV-control-transfected cells (Fig. 7b). Confocal microscopy 
showed that integrin α 5 was expressed at the plasma membrane of dopaminergic neurons differentiated from 
LV-control-transfected ES cells (Fig. 7c). We confirmed that Venus expression in TH-positive neurons was main-
tained in both clones. Although more than 90% of colonies from LV-control-transfected cells were positive for 
neuron-specific β -III tubulin (TuJ1), more than 50% of colonies from LV-integrin α 5-transfected cells were neg-
ative for TuJ1 (Fig. 7d). Flow cytometry demonstrated that the proportion of TuJ1-positive cells to total ES cells 
was significantly decreased by transfection with LV-integrin α 5 (Fig. 7e). Regardless of the inefficiency of neural 
differentiation, immunofluorescence double-staining demonstrated that the proportion of TH-positive cells to 
TuJ1-positive cells was similar between LV-control- and LV-integrin α 5- transfected cells (Fig. 7f). To examine 
the effect of integrin α 5 overexpression on dopaminergic neurite outgrowth, ES cell-derived dopaminergic neu-
rons were replated on striatal cultures. We measured the total neurite lengths of Venus-positive dopaminergic 
neurons, and overexpression of integrin α 5 in dopaminergic neurons enhanced dopaminergic neurite outgrowth 
on striatal cultures (Fig. 7g). In addition, the difference between LV-control- and LV-integrin α 5- transfected 
groups in dopaminergic neurite outgrowth expanded over time (1–3 days) (Fig. 7h).
Discussion
In this study, we demonstrated that both pharmacological and genetic inhibition of integrin α 5β 1 suppressed the 
dopaminergic neurite outgrowth on striatal neurons. Furthermore, we showed that overexpression of integrin α 5 
enhanced the neurite outgrowth of stem cell-derived dopaminergic neurons on striatal cells. These findings sug-
gest that integrin α 5β 1 expression on dopaminergic neurons plays an important role in the dopaminergic neurite 
outgrowth on striatal neurons.
Figure 6. Transduction of integrin α5 in undifferentiated ES cells by lentiviral vectors. (a) Full-length 
mouse integrin α 5 mRNA was isolated from whole brains. Integrin α 5 cDNA was amplified with PCR using 
specific primers. (b) Structure of the lentiviral vector expressing integrin α 5 and/or Venus under the control of 
the EF-1α promoter. The integrin α 5 gene (Itga5) was incorporated upstream of the internal ribosome entry site 
2 (IRES2) region. The translation of Venus was initiated via IRES2. (c,d) Expression of Venus and integrin α 5 in 
undifferentiated ES cells. Mouse ES cells were transfected with lentiviral vectors, and a fluorescent colony of ES 
cells was picked under the microscope to obtain a single clone. Scale bar = 50 μ m.
www.nature.com/scientificreports/
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Figure 7. The effect of integrin α5 overexpression on the neurite outgrowth of ES cell-derived 
dopaminergic neurons on striatal cultures. (a) Expression of Nurr1 and Ptx3 mRNA during differentiation of 
ES cells. ES cells transfected with lentiviral vectors were differentiated with the SDIA method for 12 days.  
(b) Expression of integrin α 5 in differentiated ES cells. ES cells transfected with lentiviral vectors were 
differentiated with the SDIA method for 14 days. (c) Integrin α 5 expression in TH-positive cells differentiated 
from LV-control transfected ES cells. Scale bar = 10 μ m. (d) Venus expression in TH-positive cells differentiated 
www.nature.com/scientificreports/
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Our previous report showed that in paired-cultivation conditions, dopaminergic axons prefer to extend to the 
striatal cell region rather than the spinal cell region10. Diffusible and/or membrane-bound factors derived from 
striatal cells enhance the maturation of dopaminergic neurons20,21. In organotypic co-cultures of mesencephalic 
and striatal slices, the dopaminergic innervation of striatal slices is thought to result from adhesive interactions 
rather than from diffusible substances22. However, the axon-promoting factors involved in the dopaminergic 
neurite outgrowth on striatal neurons remain unknown. In paired-cultures with striatal cells, mesencephalic 
dopaminergic neurites extended along striatal neurons but not striatal astrocytes. This observation indicates that 
cell adhesion molecules between dopaminergic neurites and striatal neurons are important for the dopaminergic 
neurite outgrowth on striatal neurons. In contrast, CM derived from striatal cultures did not enhance dopaminer-
gic neurite outgrowth, suggesting a small contribution of humoral factors to dopaminergic neurite outgrowth in 
our cultures. Because the concentration gradients of chemoattractants are important for the directional guidance 
of neurite outgrowth23, the exchange for CM derived from striatal cultures may be insufficient for the outward 
extension of dopaminergic neurites from the mesencephalic cell region. Interestingly, GDNF, which enhanced 
the outward extension of dopaminergic neurites from the mesencephalic cell region in mesencephalic cells only 
cultures, had no effect in paired-cultures of mesencephalic and striatal cells. This finding suggests that the inter-
action with striatal cells and GDNF share the same signaling pathway to promote the extension of dopaminergic 
neurites. We did not detect GDNF in the CM derived from paired-cultures of mesencephalic and striatal cells 
(data not shown).
GDNF exert its biological effects via GDNF family receptor-α 1 (GFRα 1) and RET tyrosine kinase24. In addi-
tion to RET, GFRα 1 directly interacts with NCAM and integrin β 112. Notably, NCAM and integrin α V participate 
in GDNF-induced dopaminergic neurite outgrowth11,13. Our pharmacological analysis revealed that integrin, 
rather than NCAM, participated in dopaminergic neurite outgrowth to the striatal cell region. Integrins are α β 
heterodimers, and to date, 8β subunits have been reported to assemble with 18α subunits to form 24 distinct inte-
grins25. Among them, the RGD-binding integrins (α 5β 1, α 8β 1, α Vβ 1, α Vβ 3, α Vβ 5, α Vβ 6, α Vβ 8, and α IIbβ 3) 
share the ability to recognize ligands containing an RGD tripeptide active site. We also clarified the involvement 
of integrin α 5β 1 in dopaminergic neurite outgrowth to the striatal cell region using specific pharmacological 
inhibitors. The dopaminergic neurites preferred to extend on a fibronectin matrix. These results suggest that 
integrin α 5β 1 expression on dopaminergic neurons plays an important role in dopaminergic neurite outgrowth 
to the striatal cell region. However, the involvement of other integrins cannot be excluded because dopaminergic 
neurites also showed extension on a collagen matrix. In accordance with a previous report in which integrin 
α 5 and β 1 mRNAs were expressed in the substantia nigra and the ventral tegmental area26, we confirmed integrin 
α 5β 1 mRNA expression in mesencephalic cultures and detected the expression of the corresponding proteins 
on almost all dopaminergic neurons. Our previous study10 reports that the percentage of dopaminergic neurons 
that express G-protein-activated inwardly rectifying potassium channel (GIRK)-2 and calbindin were 48% and 
46%, respectively, in this cultures. Although mesencephalic dopaminergic neurons could be divided into three 
distinct nuclei such as A8, A9 and A1027, expression of integrin α 5β 1 on dopaminergic neurons seems to be not 
restricted to GIRK-2-positive A9 cells in the substantia nigra. These findings suggest that integrin α 5β 1 expres-
sion on dopaminergic neurons does not necessarily participate in axonal guidance of the nigrostriatal dopamin-
ergic projection.
Importantly, integrin α 5 and β 1 mRNAs were also expressed in striatal cultures. To clarify the involvement of 
integrin α 5β 1 expression on dopaminergic neurons, we selectively knock downed integrin α 5 in mesencephalic 
and striatal cultures using a genetic-based approach. Integrin α 5 assembles only with integrin β 1, whereas integ-
rin β 1 assembles with integrin α 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, V25. That is why knockdown of integrin α 5 is neces-
sary and sufficient to suppress the function of integrin α 5β 1. Knockdown of integrin α 5 in dopaminergic neurons 
suppressed neurite outgrowth to the striatal cell region. The knockdown of integrin α 5 in non-dopaminergic 
mesencephalic and striatal cells had no effect on neurite outgrowth. Therefore, we conclude that integrin α 5β 1 
expression on dopaminergic neurons plays an important role in neurite outgrowth to the striatal cell region.
To enhance the dopaminergic neurite outgrowth on striatal neurons, we attempted to overexpress integrin 
α 5 in dopaminergic neurons. Because of the size of integrin α 5 coding sequence, the lentiviral titer of integrin 
α 5-expressing vector was much lower than that of control vectors. The difference in viral titers made it difficult to 
equalize the infection efficiency in dopaminergic neurons of mesencephalic cultures. Therefore, we transduced 
mouse ES cells to stably express integrin α 5 using lentiviral vectors. The elongation factor-1α (EF-1α ) promoter 
was reported to be ineffective in TH-positive cells differentiated from ES cells28. However, we showed that expres-
sion of transgenes under the control of the EF-1α promoter, although reduced, was maintained in dopaminergic 
neurons derived from ES cells in some clones. However, when integrin α 5-overexpressing ES cells were differen-
tiated with the SDIA method, a large number of TuJ1-negative colonies appeared, thus resulting in a reduction in 
neural differentiation efficiency. This effect may be due to the promotion of endodermal differentiation of ES cells 
from transfected ES cells. The lower images show a TuJ1-negative colony from LV-integrin α 5 transfected cells. 
Scale bar = 200 μ m. (e) The effect of integrin α 5 overexpression on neural differentiation efficiency of ES cells. 
ES cell-derived colonies were detached from feeder cells after 14 days of differentiation and then dissociated into 
single cells. These cells were processed for Venus and β -III tubulin (TuJ1) immunostaining and analyzed by flow 
cytometry. (f) The effect of integrin α 5 overexpression on dopaminergic differentiation efficiency of ES cells.  
(g and h) The effect of integrin α 5 overexpression on the neurite length of ES cell-derived dopaminergic 
neurons. ES cell-derived colonies were detached from feeder cells after 13 days of differentiation and 
then dissociated into single cells. These cells were replated on striatal cultures and then processed for 
immunostaining after cultivation for the indicated times. Representative images (g) were obtained 2 days after 
cultivation on striatal cultures. Scale bar = 100 μ m. n = 10–18. **p < 0.01 and ***p < 0.001 vs. LV-control.
www.nature.com/scientificreports/
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by integrin α 5β 129,30. Regardless, we successfully prepared integrin α 5-overexpressing dopaminergic neurons 
differentiated from ES cells. Furthermore, we showed that overexpression of integrin α 5 enhanced dopaminergic 
neurite outgrowth on striatal cells. In support of our finding that integrin α 5 plays a role in neurite outgrowth, 
expression of integrin α 5 in neuron-like cells conferred neurite outgrowth on fibronectin31. Myosin light chain 
kinase can function downstream of integrin activation via extracellular signal-regulated kinase32. It is proposed 
that retrograde actin flow driven by myosin, which is activated by myosin light chain kinase, participates in 
axonal elongation33.
The ligands for integrin α 5β 1 expressed on striatal neurons remain unknown. Dopaminergic axons origi-
nating from grafts run parallel to the neurites of striatal medium-sized spiny neurons, which are the target cells 
for dopaminergic innervation34. This finding suggests the existence of specific adhesion molecules on striatal 
neurons for dopaminergic innervation. Recently, it was reported that integrin α 5 is highly expressed in stri-
atal neurons innervated by nigral dopaminergic neurons35. However, integrins are known to form heterophilic 
interactions at cell-cell adhesions. Fibronectin, which is the most recognized ligand for integrin α 5β 1, is mainly 
produced in astrocytes and fibroblasts36. Fibronectin expression is increased by cytokines and injury37. Moreover, 
the L1 cell adhesion molecule, a disintegrin and metalloproteinases-15 and -17 functionally interact with integrin 
α 5β 118,38,39. Especially, L1 is reported to enhance dopaminergic neurite outgrowth in mesencephalic cultures40. 
Further investigations are needed to elucidate the integrin α 5β 1 ligands expressed on striatal neurons.
In summary, we showed that integrin α 5β 1 expression on dopaminergic neurons plays a role in the dopamin-
ergic neurite outgrowth on striatal neurons. The present study aids in the understanding of how axons extend to 
their target areas during development. In addition, our findings suggest that integrin α 5 overexpression in dopa-
minergic neurons promote the neurite outgrowth on striatal neurons.
Materials and Methods
Materials. Human GDNF was purchased from Alomone Labs (Jerusalem, Israel). The neural cell adhesion 
molecule (NCAM) function-blocking antibody (AB5032) was purchased from Merck Millipore (Billerica, MA, 
USA). RGDS was purchased from Peptide Institute (Osaka, Japan). RGES was purchased from Abbiotec (San 
Diego, CA, USA). Cyclo(RGDfV) was obtained from ENZO Life Sciences (Farmingdale, NY, USA). ATN-161 
(Ac-PHSCN-NH2) and A5-1 (VILVLF) were synthesized by Medical & Biological Laboratories (Nagoya, Japan). 
The anti-integrin α 5 function-blocking antibody (HMa5-1) was purchased from Santa Cruz (Dallas, TX, USA). 
The anti-integrin β 1 function-blocking antibody (Ha2/5), fibronectin (human), collagen I (rat), and laminin 
(mouse) were purchased from Becton-Dickinson (Franklin Lakes, NJ, USA).
Paired-cultivation of mesencephalic cells with striatal cells. Primary ventral mesencephalic and 
striatal cells were prepared from rat embryos on the 16th day of gestation. As previously described10,41, mesen-
cephalic cells were adjacently paired-cultured with striatal cells using a water-repellent isolation wall. Briefly, the 
isolation wall (1.0-mm thick) was placed on a polyethylenimine-coated coverslip in a 35-mm culture dish. The 
mesencephalic cell suspension (120 μ L) was plated inside the isolation wall (3.0 × 105 cells/cm2), and the striatal 
cell suspension (1.5 mL) was plated outside the isolation wall (3.0 × 105 cells/cm2). The isolation wall was removed 
24 h after plating. Cultures were maintained in Eagle’s minimum essential medium containing 10% fetal calf 
serum (1–4 days in vitro) or horse serum (5–12 days in vitro). Treatment with drugs was performed after removal 
of the isolation wall. Primary striatal astrocytes were prepared and enriched from rat embryos on the 16th day 
of gestation according to previously described procedures42. Cultures were incubated at 37 °C in an atmosphere 
of 5% CO2 in air with 100% relative humidity. All animals were treated in accordance with the guidelines of the 
Kyoto University Animal Experimentation Committee and the Japanese Pharmacological Society. This study was 
approved by Kyoto University Animal Experimentation Committee.
Induction of neural differentiation of mouse embryonic stem (ES) cells. Undifferentiated mouse 
ES cells (EB5, kindly provided by Dr. Hitoshi Niwa, RIKEN Center for Developmental Biology; Kobe, Japan) 
were maintained on gelatin-coated dishes in Glasgow minimum essential medium supplemented with 1% 
fetal calf serum, 5% knockout serum replacement (Thermo Fisher Scientific, Waltham, MA, USA), 2 mM glu-
tamine, 0.1 mM nonessential amino acids, 1 mM pyruvate, 0.1 mM 2-mercaptoethanol, and 2,000 U/ml leukemia 
inhibitory factor (Nacalai Tesque, Kyoto, Japan). EB5 cells carry the blasticidin S-resistance gene driven by the 
Oct3/4 promoter (active in the undifferentiated state) and were maintained in medium containing 20 μ g/ml 
blasticidin S to eliminate differentiated cells43,44. Dopaminergic neurons were differentiated from mouse ES cells 
using the SDIA method as previously described19. Briefly, ES cells were co-cultured on PA6 stromal cells at a 
single-cell density in differentiation medium (Glasgow minimum essential medium supplemented with 10% 
knockout serum replacement, 2 mM glutamine, 0.1 mM nonessential amino acids, 1 mM pyruvate, and 0.1 mM 
2-mercaptoethanol). For the replating of ES cell-derived cells on striatal cells, ES cell-derived colonies were 
detached from PA6 cells after 13 days of differentiation by incubation with collagenase type IV (Sigma-Aldrich, 
St. Louis, MO, USA) for 3 min at 37 °C. The detached colonies were isolated by spontaneous sedimentation, and 
gently triturated into single cells in the presence of Dispase (Thermo Fisher Scientific). ES cell-derived cells were 
replated on striatal cultures in the differentiation medium.
Immunocytochemistry. Immunocytochemistry was performed as previously described10. Following fixa-
tion with 4% paraformaldehyde, cells were sequentially incubated with 0.2‒ 0.5% Triton X-100, primary antibod-
ies, and secondary antibodies. For diaminobenzidine staining, cells were incubated with the avidin–biotinylated 
horseradish peroxidase complex (Vector Laboratories, Burlingame, CA, USA) and reacted with a diaminobenzi-
dine solution (Dojindo Laboratories, Kumamoto, Japan). For nuclear staining, cells were incubated with Hoechst 
33258 (100 μ g/mL). The following antibodies were commercially obtained: anti-TH from Merck Millipore, 
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anti-MAP2 from Sigma-Aldrich, anti-pNF (SMI 31) and anti-neuronal class III β -tubulin (Tuj1) from Covance 
(Princeton, NJ, USA), anti-GFP from Nacalai Tesque, anti-GFAP from Merck Millipore, anti-integrin α 5 (HMa5-1) 
and anti-integrin β 1 (N-20) from Santa Cruz. Images of living or immunostained cells were obtained using an 
IX81 inverted research microscope (Olympus, Tokyo, Japan), a BZ-8100 fluorescence microscope (Keyence, 
Osaka, Japan), and an A1RMP multiphoton confocal microscope (Nikon, Tokyo, Japan). The fluorescence of 
immunostained cells was analyzed on a BD FACSAria III cell sorter (Becton-Dickinson).
Measurement of dopaminergic neurite length. To measure dopaminergic neurite length in the 
paired-cultures of mesencephalic and striatal cells, cultures were processed for TH immunostaining. As previ-
ously described10, the borderline of the mesencephalic cell region was defined as the position of the most laterally 
located TH-positive dopaminergic soma. The distance from TH-positive dopaminergic growth cones to the bor-
derline was measured and defined as the neurite length. The sum of all dopaminergic neurite lengths in a width 
of 890 μ m was calculated. To produce a continuous image, several photographs were merged using a BZ Analyzer 
(Keyence). There were four subjects for each experiment.
The measurements of neurite length of ES-derived dopaminergic neurons were completed using Image J soft-
ware (National Institutes of Health, Bethesda, MD, USA) with the NeuronJ plug-in.
RT-PCR. Total RNA was isolated using a High Pure RNA Isolation Kit (Roche, Basel, Switzerland) according 
to the manufacturer’s instructions. Total RNA was reverse-transcribed using oligo (dT) primers and RT-PCR was 
performed using a PrimeScript RT-PCR Kit (Takara Bio, Shiga, Japan) according to the manufacturer’s instruc-
tions. Table 1 shows the primer sets used for amplication. The PCR conditions included 30 cycles of 30 s at 94 °C, 
30 s at 60 °C, and 30 s at 72 °C.
Generation of lentiviral vectors and in vitro transduction. Plasmids, which were required to gen-
erate the third-generation self-inactivated human immunodeficiency virus-1–based lentiviral vectors, were 
kindly provided by Dr. Hiroyuki Miyoshi (RIKEN BioResource Center). Integrin α 5 shRNA was prepared by 
Gene name Amplicon size (bp) Primer sequences
Integrin α 1 115
5′ -ATGCCTTGCGTGAAGTTGG-3′ 
5′ -GAAATCCTCCATTCGGGTTG-3′ 
Integrin α 2 101
5′ -TTGCTGTTGGCTATGGTTGC-3′ 
5′ -TCTGTGGTCTCGTCCGTCTC-3′ 
Integrin α 4 112
5′ -CGAGTTTCAAGCAGTGGAGAG-3′ 
5′ -GATGCCCAAGGTGGTATGTG-3′ 
Integrin α 5 99
5′ -GCTGCATTTCCGAGTCTGG-3′ 
5′ -TAGGGCATCTTCAGGGCTTC-3′ 
Integrin α 6 120
5′ -GAGCTCCCTATGACGATCTGG-3′ 
5′ -CAGCGATTGAGTAGCCGAAG-3′ 
Integrin α 7 127
5′ -CAGGCAGATGGGGATGATG-3′ 
5′ -AGGCATTCTCGTTGGACAGG-3′ 
Integrin α 8 104
5′ -AGGCCAGAGCATTTCAAATACAG-3′ 
5′ -GGTGGTTGTGGAGGAAGAGG-3′ 
Integrin α V 119
5′ -TTAAGACGCCCGAAAAGAATG-3′ 
5′ -AGCAGTTCCACAGCCCAAAG-3′ 
Integrin β 1 139
5′ -GACCTGCCTTGGTGTCTGTG-3′ 
5′ -GGGCAACTTCTCCCTGCTTT-3′ 
Integrin β 2 118
5′ -TGGTGAGAAGCAGGCAGAGA-3′ 
5′ -TACCTCAGGGAGGGATGTGG-3′ 
Integrin β 3 123
5′ -GGACGGAAACGCTTACAACATC-3′ 
5′ -ACCAGGAGGAGGACACCAATC-3′ 
Integrin β 4 145
5′ -AAACTGCAAGGAGAACGCATC-3′ 
5′ -AGGCAGACTCGGTGGAGAAC-3′ 












Table 1.  Primer sets used in PCR analysis for mRNA expression.
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annealing 67 base pair sense and antisense oligos that contained a 19-base stem from the rat integrin α 5 sequence 
(5′ -CACTAGCCAACCAGGAGTA-3′ )45 and a 15-base loop (5′ -ACGTGTGCTGTCCGT-3′ ). Control shRNA 
contained a non-targeting stem (5′ -ACGTGACACGTTCGGAGAA-3′ ). The annealed oligos were subcloned into 
pENTER-H1 at the BglII and XbaI sites, and were recombined into CS-RfA-EVBsd using Gateway LR Clonase II 
(Thermo Fisher Scientific). Mouse integrin α 5 cDNA was amplified by PCR from mouse whole brain cDNA, and 
the coding region was verified by DNA sequencing. The cDNA was subcloned into CSII-EF-RfA-IRES2-Venus by 
replacing the RfA Gateway cassette. The vector contains an EF-1α promoter and an internal ribosomal entry site 
2 (IRES2) followed by Venus, which is a variant of yellow fluorescent protein46. The lentiviral vectors expressing 
Venus only or integrin α 5 followed by Venus were generated by transient cotransfection of HEK293T cells with 
CSII-EF-IRES2-Venus or CSII-EF-Itga5-IRES2-Venus, respectively, the packaging construct (pCAG-HIVgp), 
and the envelop- and Rev-expressing construct (pCMV-VSV-G-RSV-Rev). Two days after transfection, the 
vector-containing supernatant was collected, filtered through a 0.22-μ m-pore-size filter, and concentrated by 
centrifugation at 50,000 g for 2 hours at 20 °C. The virus pellet was resuspended in culture medium and stored 
at − 80 °C until use. For the enhancement of lentiviral infection, polybrene (8 μ g/mL) was added to the lentiviral 
vector-containing medium.
Western blot analysis. The Western blot analysis was conducted as previously described47, except that the 
detection of integrin α 5 was performed under non-reducing conditions. The following antibodies were commer-
cially obtained: anti-integrin α 5 (AB1928) from Merck Millipore and anti-β -actin (AC-15) from Sigma-Aldrich.
Statistics. The statistical significance of the differences between three or more groups was analyzed with 
a one-way analysis of variance (ANOVA) followed by post-hoc multiple comparisons using the Turkey’s test. 
Statistical significance was defined as p < 0.05. Data are expressed as the mean ± standard error of the mean 
(SEM).
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